TrialBMC pediatrics2013

Omega-3 fatty acids for treatment of non-alcoholic fatty liver disease: design and rationale of randomized controlled trial.

Wojciech Janczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.